Shelter Pharma, 543963, Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

59.30
9.59
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

54.84
N/A
1.71

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

EBITDA CAGR (%)

10 Years
5 Years
3 Years

PAT CAGR (%)

10 Years
5 Years
3 Years

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

EV:EBITDA (Average)

8 Years
5 Years
3 Years

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 24 Mar 23 Mar 22 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales - 40.02 36.15 30.06 30.01 28.14 25.06 23.13 21.16 18.62 14.99 Net Sales Growth - 10.71% 20.26% 0.17% 6.65% 12.29% 8.34% 9.31% 13.64% 24.22% Cost Of Goods Sold - 28.92 26.25 25.85 28.73 26.34 22.29 18.05 16.55 15.85 13.19 Gross Profit - 11.10 9.90 4.21 1.27 1.80 2.77 5.08 4.61 2.77 1.80 GP Margin - 27.74% 27.39% 14.01% 4.23% 6.40% 11.05% 21.96% 21.79% 14.88% 12.01% Total Expenditure - 31.24 28.09 27.32 30.70 27.98 24.96 20.71 18.98 16.88 13.87 Power & Fuel Cost - 0.07 0.06 0.05 0.06 0.05 0.05 0.04 0.04 0.02 0.00 % Of Sales - 0.17% 0.17% 0.17% 0.20% 0.18% 0.20% 0.17% 0.19% 0.11% 0% Employee Cost - 0.63 0.45 0.35 0.47 0.43 0.28 0.19 0.17 0.21 0.28 % Of Sales - 1.57% 1.24% 1.16% 1.57% 1.53% 1.12% 0.82% 0.80% 1.13% 1.87% Manufacturing Exp. - 0.24 0.27 0.16 0.28 0.15 0.29 0.25 0.24 0.02 0.00 % Of Sales - 0.60% 0.75% 0.53% 0.93% 0.53% 1.16% 1.08% 1.13% 0.11% 0% General & Admin Exp. - 0.70 0.56 0.56 0.91 0.86 1.64 1.44 1.42 0.61 0.39 % Of Sales - 1.75% 1.55% 1.86% 3.03% 3.06% 6.54% 6.23% 6.71% 3.28% 2.60% Selling & Distn. Exp. - 0.22 0.10 0.04 0.18 0.15 0.42 0.68 0.55 0.11 0.00 % Of Sales - 0.55% 0.28% 0.13% 0.60% 0.53% 1.68% 2.94% 2.60% 0.59% 0% Miscellaneous Exp. - 0.45 0.39 0.31 0.07 0.00 0.00 0.06 0.00 0.06 0.00 % Of Sales - 1.12% 1.08% 1.03% 0.23% 0% 0% 0.26% 0% 0.32% 0% EBITDA - 8.78 8.06 2.74 -0.69 0.16 0.10 2.42 2.18 1.74 1.12 EBITDA Margin - 21.94% 22.30% 9.12% -2.30% 0.57% 0.40% 10.46% 10.30% 9.34% 7.47% Other Income - 0.01 0.00 0.02 0.83 0.00 0.03 0.02 0.00 0.05 0.04 Interest - 0.26 0.03 0.08 0.01 0.01 0.00 0.00 0.17 0.35 0.30 Depreciation - 0.25 0.16 0.17 0.07 0.10 0.09 0.04 0.02 0.06 0.06 PBT - 8.28 7.88 2.51 0.06 0.05 0.02 2.40 1.99 1.39 0.81 Tax - 2.08 1.78 0.67 0.01 0.01 0.00 0.72 0.63 0.48 0.17 Tax Rate - 25.12% 25.50% 26.69% 16.67% 20.00% 0.00% 30.00% 31.19% 34.53% 20.99% PAT - 6.20 5.21 1.84 0.05 0.05 0.02 1.67 1.38 0.91 0.63 PAT before Minority Interest - 6.20 5.21 1.84 0.05 0.05 0.02 1.67 1.38 0.91 0.63 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 15.49% 14.41% 6.12% 0.17% 0.18% 0.08% 7.22% 6.52% 4.89% 4.20% PAT Growth - 19.00% 183.15% 3,580.00% 0.00% 150.00% -98.80% 21.01% 51.65% 44.44% EPS - 5.34 4.49 1.59 0.04 0.04 0.02 1.44 1.19 0.78 0.54

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 24 Mar 23 Mar 22 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 08
Shareholder's Funds 35.82 14.55 8.93 10.84 9.18 4.24 3.36 2.77 2.74 2.39 Share Capital 11.56 7.74 0.48 0.45 0.45 0.40 0.40 0.40 0.40 0.40 Total Reserves 24.26 6.80 8.44 10.38 8.73 3.84 2.96 2.37 2.34 1.99 Non-Current Liabilities 0.59 0.65 0.20 0.00 0.00 0.01 0.08 1.85 1.11 1.08 Secured Loans 0.57 0.00 0.00 0.00 0.00 0.00 0.00 1.58 0.62 0.38 Unsecured Loans 0.00 0.48 0.06 0.00 0.00 0.01 0.07 0.25 0.48 0.69 Long Term Provisions 0.05 0.05 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 1.47 6.25 3.71 4.71 3.91 5.67 4.41 0.25 0.38 0.14 Trade Payables 0.71 0.47 0.32 0.59 0.49 0.26 2.13 0.05 0.07 0.10 Other Current Liabilities 0.06 2.62 2.69 0.05 0.03 0.04 0.06 0.02 0.18 0.03 Short Term Borrowings 0.00 1.30 0.04 2.07 2.11 4.71 2.03 0.00 0.00 0.00 Short Term Provisions 0.70 1.85 0.65 2.01 1.28 0.65 0.20 0.18 0.13 0.01 Total Liabilities 37.88 21.45 12.84 15.55 13.09 9.92 7.85 4.87 4.23 3.61 Net Block 3.58 1.85 1.45 2.35 1.88 1.80 1.85 1.91 2.14 2.03 Gross Block 5.70 3.72 3.17 2.67 2.14 2.01 1.85 1.99 2.17 2.04 Accumulated Depreciation 2.13 1.88 1.72 0.32 0.27 0.20 0.00 0.09 0.03 0.01 Non Current Assets 8.16 2.73 3.01 2.35 1.88 1.80 1.86 1.91 2.14 2.03 Capital Work in Progress 0.00 0.00 0.55 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 0.68 0.68 0.68 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 3.90 0.21 0.33 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 29.72 18.72 9.83 13.21 11.22 8.11 5.99 2.95 2.08 1.57 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 9.93 7.96 5.67 5.26 4.12 1.25 1.53 0.81 1.02 0.71 Sundry Debtors 8.85 8.19 1.61 4.30 3.49 4.18 4.23 1.89 0.81 0.55 Cash & Bank 5.04 0.43 0.10 0.38 0.08 0.07 0.02 0.05 0.05 0.10 Other Current Assets 5.90 0.00 0.00 0.00 3.54 2.60 0.21 0.20 0.21 0.21 Short Term Loans & Adv. 5.90 2.13 2.45 3.27 3.54 2.60 0.20 0.15 0.16 0.15 Net Current Assets 28.24 12.47 6.12 8.49 7.31 2.44 1.58 2.70 1.70 1.43 Total Assets 37.88 21.45 12.84 15.56 13.10 9.91 7.85 4.87 4.23 3.61

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 24 Mar 23 Mar 22 Mar 10 Mar 09 Mar 08
Cash From Operating Activity -1.85 -0.96 0.52 0.00 0.00 0.00 PBT 8.40 7.05 2.51 0.00 0.00 0.00 Adjustment 0.58 0.17 0.05 0.00 0.00 0.00 Changes in Working Capital -9.26 -8.19 -2.04 0.00 0.00 0.00 Cash after chg. in Working capital -0.28 -0.96 0.52 0.00 0.00 0.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.57 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -4.54 0.11 -0.85 0.00 0.00 0.00 Net Fixed Assets -1.98 0.00 -1.73 0.18 -0.13 Net Investments 0.00 0.00 -0.68 0.00 0.00 Others -2.56 0.11 1.56 -0.18 0.13 Cash from Financing Activity 11.01 1.18 0.06 0.00 0.00 0.00 Net Cash Inflow / Outflow 4.61 0.33 -0.27 0.00 0.00 0.00 Opening Cash & Equivalents 0.43 0.10 0.37 0.00 0.00 0.00 Closing Cash & Equivalent 5.04 0.43 0.10 0.00 0.00 0.00

Financial Ratios

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 08
Book Value (Rs.) 30.17 17.57 10.31 206.99 170.15 68.58 84.09 29.73 24.22 15.67 ROA 20.90% 30.37% 15.94% 11.67% 12.01% 10.25% 9.94% 4.81% 8.68% 6.81% ROE 25.58% 48.22% 25.95% 19.54% 26.40% 29.81% 27.77% 20.29% 42.68% 39.33% ROCE 33.62% 59.61% 36.17% 22.50% 25.25% 26.91% 26.11% 29.22% 36.53% 17.42% Fixed Asset Turnover 8.49 10.49 9.57 9.63 10.20 9.65 7.79 6.15 5.48 3.11 Receivable days 77.72 49.47 14.36 61.36 66.14 82.44 74.53 38.46 21.47 31.74 Inventory Days 81.59 68.85 58.83 73.90 46.30 27.29 28.52 26.12 27.29 40.59 Payable days 7.45 5.49 4.48 9.95 6.86 26.68 28.12 1.94 2.99 5.88 Cash Conversion Cycle 151.86 112.83 68.72 125.30 105.59 83.05 74.93 62.63 45.77 66.45 Total Debt/Equity 0.02 0.13 0.02 0.22 0.27 1.72 0.62 1.54 1.14 1.72 Interest Cover 32.42 278.06 32.60 2441.20 13.03 5.01 3.67 2.81 2.81 5.93

Top Investors:

mayuri shripal vora

Annual Reports:

News Update:

Shelter Pharma secures order from FIRSTVET Veterinary Medicines Trading
30th Oct 2024, 10:28 AM

The said order is expected to be executed within 2 months
Read More
Shelter Pharma secures order from Genet International
29th Oct 2024, 15:42 PM

The total order is worth $12,500
Read More
Shelter Pharma secures order from Taha Drugs & Chemical
23rd Oct 2024, 15:29 PM

Total order is worth $80,000
Read More
Shelter Pharma secures order worth $17,700
18th Sep 2024, 14:41 PM

The order is to be executed within 2 months
Read More

Shelter Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543963 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update:

Shelter Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543963 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update: